Cellectar Biosciences, Inc. (CLRB)
3.23
+0.27
(+9.12%)
USD |
NASDAQ |
Mar 12, 16:00
3.26
+0.03
(+0.93%)
After-Hours: 04:06
Cellectar Biosciences Total Liabilities (Quarterly) : 5.059M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| EyePoint Plc | 57.88M |
| Ocugen, Inc. | 56.46M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 46.54M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.98M |
| Shareholders Equity (Quarterly) | 9.919M |
| Debt to Equity Ratio | 0.0413 |
| Current Ratio | 2.956 |
| Net Debt Paydown Yield | 0.16% |